Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Status:
Completed
Trial end date:
2017-11-28
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of Avastin
(bevacizumab) and Torisel (temsirolimus) that can be given, in combination, to patients with
advanced cancer that has spread or is unable to be surgically removed. The safety of this
drug combination will also be studied.